Journal of Cardiac Failure
Volume 16, Issue 3 , Pages 250-259 , March 2010

Right Ventricular Heart Failure From Pulmonary Embolism: Key Distinctions From Chronic Pulmonary Hypertension

  • John A. Watts, PhD

      Affiliations

    • Emergency Medicine Research, Carolinas Medical Center, Charlotte, NC
    • Corresponding Author InformationReprint requests: John A. Watts, PhD, Emergency Medicine Preclinical Research, Room 302 Cannon Research Center, Carolinas Medical Center, 1542 Garden Terrace, Charlotte, NC 28203. Tel: 704 355-8427, Fax: 704 355-5620.
    • ,
  • Michael R. Marchick, MD

      Affiliations

    • Emergency Medicine Research, Carolinas Medical Center, Charlotte, NC
    • ,
  • Jeffrey A. Kline, MD

      Affiliations

    • Emergency Medicine Research, Carolinas Medical Center, Charlotte, NC

Received 15 September 2009 ,Revised 5 November 2009 ,Accepted 30 November 2009.

References 

  1. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37:183–188
  2. Becattini C, Agnelli G. Predictors of mortality from pulmonary embolism and their influence on clinical management. Thromb Haemost. 2008;100:747–751
  3. Sanchez O, Trinquart L, Colombet I, Durieux P, Huisman MV, Chatellier G, et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J. 2008;29:1569–1577
  4. Stevinson BG, Hernandez-Nino J, Rose G, Kline JA. Echocardiographic and functional cardiopulmonary problems six months after first-time pulmonary embolism in previously healthy patients. Eur Heart J. 2007;28:2517–2524
  5. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117:1436–1448
  6. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114:1883–1891
  7. Hemnes AR, Champion HC. Right heart function and haemodynamics in pulmonary hypertension. Int J Clin Practice. 2008;62(Suppl. 160):11–19
  8. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119:2250–2294
  9. McIntyre KM, Sasahara AA. Determinants of right ventricular function and hemodynamics after pulmonary embolism. Chest. 1974;65:534–543
  10. Hsiao SH, Yang SH, Wang WC, Lee CY, Lin SK, Liu CP. Usefulness of regional myocardial performance index to diagnose pulmonary embolism in patients with echocardiographic signs of pulmonary hypertension. Am J Cardiol. 2006;98:1652–1655
  11. Hsiao SH, Lee CY, Chang SM, Yang SH, Lin SK, Huang WC. Pulmonary embolism and right heart function: insights from myocardial Doppler tissue imaging. J Am Soc Echocard. 2006;19:822–828
  12. Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest. 2002;121:877–905
  13. Watts JA, Gellar MA, Obraztsova M, Kline JA, Zagorski J. Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in rats. Int J Exp Pathol. 2008;89:389–399
  14. Iwadate K, Doi M, Tanno K, Katsumura S, Ito H, Sato K, et al. Right ventricular damage due to pulmonary embolism: examination of the number of infiltrating macrophages. Forensic Sci, Int. 2003;134:147–153
  15. Kaczynska A, Szulc M, Styczynski G, Kostrubiec M, Pacho R, Pruszczyk P. Right ventricle injury during acute pulmonary embolism leads to its remodeling. Int J Cardiol. 2008;125:120–121
  16. Scridon T, Scridon C, Skali H, Alvarez A, Goldhaber SZ, Solomon SD. Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol. 2005;96:303–305
  17. Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008;358:1037–1052
  18. Klings ES. Pulmonary hypertension of sickle cell disease: more than just another lung disease. American Journal of Hematology. 2008;83:4–5
  19. Dessap MA, Leon R, Habibi A, Nzouakou R, Roudot-Thoraval F, Adnot S, et al. Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med. 2008;177:646–653
  20. Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med. 2008;359:2254–2265
  21. Nakamura H, Adachi H, Sudoh A, Yagyu H, Kishi K, Oh-ishi S, et al. Subacute cor pulmonale due to tumor embolism. Intern Med. 2004;43:420–422
  22. Archer S, Michelakis E. The mechanism(s) of hypoxic pulmonary vasoconstriction: potassium channels, redox O(2) sensors, and controversies. News Physiol Sci. 2002;17:131–137
  23. Memtsoudis SG, Rosenberger P, Walz JM. Critical care issues in the patient after major joint replacement. J Intens Care Med. 2007;22:92–104
  24. Toledo LS, Mauad R. Complications of body sculpture: prevention and treatment. Clin Plastic Surg. 2006;33:1–11
  25. Mirski MA, Lele AV, Fitzsimmons L, Toung TJ. Diagnosis and treatment of vascular air embolism. Anesthesiology. 2007;106:164–177
  26. Sullivan DM, Watts JA, Kline JA. Biventricular cardiac dysfunction after acute massive pulmonary embolism in the rat. J Appl Physiol. 2001;90:1648–1656
  27. Eagleton MJ, Henke PK, Luke CE, Hawley AE, Bedi A, Knipp BS, et al. Inflammation and intimal hyperplasia associated with experimental pulmonary embolism. J Vasc Surg. 2002;36:581–588
  28. Sedlarik KM, Monch C, Haenselt V, Riedel E, Durschmied H. Experimental pulmonary embolism with electrically activated autologous blood. Res Exp Med. 1986;186:271–284
  29. Guarneri L, Molinari A, Casacci F, Pacei E, Cerletti C, de Gaetano G. A new model of pulmonary microembolism in the mouse. J Pharmacol Methods. 1988;20:161–167
  30. Sato H, Hall CM, Griffith GW, Johnson KF, McGillicuddy JW, Bartlett RH, et al. Large animal model of chronic pulmonary hypertension. ASAIO J. 2008;54:396–400
  31. Rectenwald JE, Deatrick KB, Sukheepod P, Lynch EM, Moore AJ, Moaveni DM, et al. Experimental pulmonary embolism: effects of the thrombus and attenuation of pulmonary artery injury by low-molecular-weight heparin. [erratum appears in J Vasc Surg. 2006 Oct;44(4):914] J Vasc Surg. 2006;43:800–808
  32. Johnson A, Malik AB. Effects of different-size microemboli on lung fluid and protein exchange. J Appl Physiol Resp Environ Exer Physiol. 1981;51:461–464
  33. Jones AE, Watts JA, Debelak JP, Thornton LR, Younger JG, Kline JA. Inhibition of prostaglandin synthesis during polystyrene microsphere-induced pulmonary embolism in the rat. Am J Physiol Lung Cell Molec Physiol. 2003;284:L1072–L1081
  34. Zagorski J, Debelak J, Gellar M, Watts JA, Kline JA. Chemokines accumulate in the lungs of rats with severe pulmonary embolism induced by polystyrene microspheres. J Immunol. 2003;171:5529–5536
  35. Watts JA, Zagorski J, Gellar MA, Stevinson BG, Kline JA. Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J Molec Cell Cardiol. 2006;41:296–307
  36. Zagorski J, Gellar MA, Obraztsova M, Kline JA, Watts JA. Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats. J Immunol. 2007;179:7820–7826
  37. Zagorski J, Sanapareddy N, Gellar MA, Kline JA, Watts JA. Transcriptional profile of right ventricular tissue during acute pulmonary embolism in rats. Physiol Genom. 2008;34:101–111
  38. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43:5S–12S
  39. Hessel MH, Steendijk P, den Adel B, Schutte CI, van der LA. Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat. Am J Physiol Heart Circ Physiol. 2006;291:H2424–H2430
  40. Jeffery TK, Wanstall JC. Comparison of pulmonary vascular function and structure in early and established hypoxic pulmonary hypertension in rats. Can J Physiol Pharmacol. 2001;79:227–237
  41. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res. 2009;104:236–244
  42. Chu D, Sullivan CC, Du L, Cho AJ, Kido M, Wolf PL, et al. A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1. Ann Thorac Surg. 2004;77:449–456
  43. Guignabert C, Izikki M, Tu LI, Li Z, Zadigue P, Barlier-Mur AM, et al. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circ Res. 2006;98:1323–1330
  44. Otto C, Hein L, Brede M, Jahns R, Engelhardt S, Grone HJ, et al. Pulmonary hypertension and right heart failure in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice. Circulation. 2004;110:3245–3251
  45. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed). [erratum appears in Chest. 2008 Oct;134(4):892] Chest. 2008;133:454S–545S
  46. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galie N, Pruszczyk P, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008;29:2276–2315
  47. Konstantinides S. Clinical practice. Acute pulmonary embolism. N Engl J Med. 2008;359:2804–2813
  48. Smulders YM. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res. 2000;48:23–33
  49. Reeves WC, Demers LM, Wood MA, Skarlatos S, Copenhaver G, Whitesell L, et al. The release of thromboxane A2 and prostacyclin following experimental acute pulmonary embolism. Prostagland Leukotrienes Med. 1983;11:1–10
  50. Todd MH, Forrest JB, Cragg DB. The effects of aspirin and methysergide, singly and in combination, on systemic haemodynamic responses to pulmonary embolism. Can Anaesth Soc J. 1981;28:373–380
  51. Breuer J, Meschig R, Breuer HW, Arnold G. Effects of serotonin on the cardiopulmonary circulatory system with and without 5-HT2-receptor blockade by ketanserin. J Cardiovasc Pharmac. 1985;7:64–66
  52. Battistini B. Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism. Can J Physiol Pharmacol. 2003;81:555–569
  53. Kapsch DN, Metzler M, Silver D. Contributions of prostaglandin F2alpha and thromboxane A2 to the acute cardiopulmonary changes of pulmonary embolism. J Surg Res. 1981;30:522–529
  54. Kline JA, Marchick MR, Hogg MM. Reduction in plasma haptoglobin in humans with acute pulmonary embolism causing tricuspid regurgitation. J Thromb Haemostasis. 2009;7:1597–1599
  55. Dias-Junior CA, Vieira TF, Moreno H, Evora PR, Tanus-Santos JE. Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension. Pulmon Pharmacol Therapeutics. 2005;18:181–186
  56. Jeffery TK, Morrell NW. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Progr Cardiovasc Dis. 2002;45:173–202
  57. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:13S–24S
  58. Dell'Italia LJ. The right ventricle: anatomy, physiology, and clinical importance. Curr Problems Cardiol. 1991;16:653–720
  59. Cho EJ, Jiamsripong P, Calleja AM, Alharthi MS, McMahon EM, Khandheria BK, et al. Right ventricular free wall circumferential strain reflects graded elevation in acute right ventricular afterload. Am J Physiol Heart Circulatory Physiol. 2009;296:H413–H420
  60. Fremont B, Pacouret G, Jacobi D, Puglisi R, Charbonnier B, de Labriolle A. Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1,416 patients. Chest. 2008;133:358–362
  61. Kline JA, Hernandez-Nino J, Rose GA, Norton HJ, Camargo CA. Surrogate markers for adverse outcomes in normotensive patients with pulmonary embolism. Crit Care Med. 2006;34:2773–2780
  62. Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Failure Rev. 2007;12:331–343
  63. Yatscoff MA, Jaswal JS, Grant MR, Greenwood R, Lukat T, Beker DL, et al. Myocardial hypertrophy and the maturation of fatty acid oxidation in the newborn human heart. Pediatr Res. 2008;64:643–647
  64. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol. 1974;36:413–459
  65. Kodde IF, van der SJ, Smolenski RT, de Jong JW. Metabolic and genetic regulation of cardiac energy substrate preference. Comp Biochem Physiol Part A. Molec Integrative Physiol. 2007;146:26–39
  66. Urashima T, Zhao M, Wagner R, Fajardo G, Farahani S, Quertermous T, et al. Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis. Am J Physiol Heart Circulatory Physiol. 2008;295:H1351–H1368
  67. Nagendran J, Gurtu V, Fu DZ, Dyck JR, Haromy A, Ross DB, et al. A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted. J Thorac Cardiovasc Surg. 2008;136:168-8
  68. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part ii: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117:1717–1731
  69. Faber MJ, Dalinghaus M, Lankhuizen IM, Bezstarosti K, Verhoeven AJ, Duncker DJ, et al. Time dependent changes in cytoplasmic proteins of the right ventricle during prolonged pressure overload. J Molec Cell Cardiol. 2007;43:197–209
  70. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest. 1997;100:2315–2324
  71. Faber MJ, Dalinghaus M, Lankhuizen IM, Bezstarosti K, Verhoeven AJ, Duncker DJ, et al. Time dependent changes in cytoplasmic proteins of the right ventricle during prolonged pressure overload. J Molec Cell Cardiol. 2007;43:197–209
  72. Sharma S, Taegtmeyer H, Adrogue J, Razeghi P, Sen S, Ngumbela K, et al. Dynamic changes of gene expression in hypoxia-induced right ventricular hypertrophy. Am J Physiol Heart Circulatory Physiol. 2004;286:H1185–H1192
  73. Ten Wolde M, Sohne M, Quak E, Mac Gillavry MR, Buller HR. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med. 2004;164:1685–1689
  74. McConnell MV, Solomon SD, Rayan ME, Come PC, Goldhaber SZ, Lee RT. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol. 1996;78:469–473
  75. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part II: risk stratification, treatment, and prevention. Circulation. 2003;108:2834–2838
  76. Schoepf UJ, Kucher N, Kipfmueller F, Quiroz R, Costello P, Goldhaber SZ. Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation. 2004;110:3276–3280
  77. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation. 2007;116:427–433
  78. Binder L, Pieske B, Olschewski M, Geibel A, Klostermann B, Reiner C, et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation. 2005;112:1573–1579
  79. Gallotta G, Palmieri V, Piedimonte V, Rendina D, De Bonis S, Russo V, et al. Increased troponin I predicts in-hospital occurrence of hemodynamic instability in patients with sub-massive or non-massive pulmonary embolism independent to clinical, echocardiographic and laboratory information. Int J Cardiol. 2008;124:351–357
  80. Jimenez D, Diaz G, Molina J, Marti D, Del Rey J, Garcia-Rull S, et al. Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism. Eur Resp J. 2008;31:853
  81. Kline JA, Zeitouni R, Marchick MR, Hernandez-Nino J, Rose GA. Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism. Am Heart J. 2008;156:308–314
  82. Kaczynska A, Pelsers MM, Bochowicz A, Kostrubiec M, Glatz JF, Pruszczyk P. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta. 2006;371:117–123
  83. van Wolferen SA, Marcus JT, Westerhof N, Spreeuwenberg MD, Marques KM, Bronzwaer JG, et al. Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J. 2008;29:120–127
  84. Pokreisz P, Marsboom G, Janssens S. Pressure overload-induced right ventricular dysfunction and remodelling in experimental hypertension: the right heart revisited. Eur Heart J. 2007;9:H75–H84
  85. Iwadate K, Tanno K, Doi M, Takatori T, Ito Y. Two cases of right ventricular ischemic injury due to massive pulmonary embolism. Forensic Sci Int. 2001;116:189–195
  86. Begieneman MP, van de Goot FR, van dB I, Noordegraaf AV, Spreeuwenberg MD, Paulus WJ, et al. Pulmonary embolism causes endomyocarditis in the human heart. Heart. 2008;94:450–456
  87. Nordenholz KE, Mitchell AM, Kline JA. Direct comparison of the diagnostic accuracy of fifty protein biological markers of pulmonary embolism for use in the emergency department. Acad Emerg Med. 2008;15:795–799
  88. Mitchell AM, Nordenholz KE, Kline JA. Tandem measurement of D-dimer and myeloperoxidase of C-reactive protein to effectively screen for pulmonary embolism in the emergency department. Acad Emerg Med. 2008;15:800–805
  89. Budev MM, Arroliga AC, Wiedemann HP, Matthay RA. Cor pulmonale: an overview. Semin Resp Crit Care Med. 2003;24:233–244
  90. Barry SP, Davidson SM, Townsend PA. Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol. 2008;40:2023–2039
  91. Umar S, Hessel M, Steendijk P, Bax W, Schutte C, Schalij M, et al. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension. Pathol Res Practice. 2007;203:863–872
  92. Buermans HP, Redout EM, Schiel AE, Musters RJ, Zuidwijk M, Eijk PP, et al. Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure. Physiol Genom. 2005;21:314–323
  93. Tuxworth WJ, Shiraishi H, Moschella PC, Yamane K, McDermott PJ, Kuppuswamy D. Translational activation of 5'-TOP mRNA in pressure overload myocardium. Basic Res Cardiol. 2008;103:41–53
  94. Cingolani HE, Perez NG, Aiello EA, Ennis IL, Garciarena CD, Villa-Abrille MC, et al. Early signals after stretch leading to cardiac hypertrophy. Key role of NHE-1. Frontiers Biosci. 2008;13:7114
  95. Akazawa H, Yasuda N, Komuro I. Mechanisms and functions of agonist-independent activation in the angiotensin II type 1 receptor. Molec Cell Endocrinol. 2009;302:140–147
  96. du Toit EF, Nabben M, Lochner A. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury. Basic Res Cardiol. 2005;100:346–354
  97. Diz DI. Future directions in cardiovascular pharmacology: examples from the Renin-Angiotensin system. Molecular Interventions. 2008;8:222–225106
  98. Ferrario CM. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotens Aldosterone Sys. 2006;7:3–14
  99. Redout EM, Wagner MJ, Zuidwijk MJ, Boer C, Musters RJ, van Hardeveld C, et al. Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species. Cardiovasc Res. 2007;75:770–781
  100. Watts JA, Gellar MA, Stuart L, Obraztsova M, Kline JA. Proinflammatory events in right ventricular damage during pulmonary embolism: effects of treatment with Ketorolac in rats. J Cardiovasc Pharmacol. 2009;54:246–252
  101. Daniel KR, Courtney DM, Kline JA. Assessment of cardiac stress from massive pulmonary embolism with 12-lead ECG. Chest. 2001;120:474–481
  102. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, Johnsson H, Jorfeldt L. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J. 1997;134:479–487
  103. Aviram G, Rogowski O, Gotler Y, Bendler A, Steinvil A, Goldin Y, et al. Real-time risk stratification of patients with acute pulmonary embolism by grading the reflux of contrast into the inferior vena cava on computerized tomographic pulmonary angiography. J Thromb Haemost. 2008;6:1488–1493
  104. Bova C, Pesavento R, Marchiori A, Palla A, Enea I, Pengo V, et al. Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up. J Thromb Haemost. 2009;7:938–944
  105. Kline JA, Zeitouni R, Marchick MR, Hernandez-Nino J, Rose GA. Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism. Am Heart J. 2008;156:308–314

PII: S1071-9164(09)01196-8

doi: 10.1016/j.cardfail.2009.11.008

Journal of Cardiac Failure
Volume 16, Issue 3 , Pages 250-259 , March 2010

Article Tools

* Image Usage & Resolution